RCWCX | WFBFX | RCWCX / WFBFX | |
Total Expense Ratio | 1.13 | 0.48 | 235% |
Annual Report Gross Expense Ratio | 1.13 | 0.48 | 235% |
Fund Existence | 23 years | 8 years | - |
Gain YTD | 6.361 | 6.696 | 95% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 9.9B | 9.9B | 100% |
Annual Yield % from dividends | 2.92 | 3.56 | 82% |
Returns for 1 year | 6.12 | 6.84 | 89% |
Returns for 3 years | 7.38 | 9.18 | 80% |
Returns for 5 years | -11.63 | -9.01 | 129% |
Returns for 10 years | 0.23 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BKLSX | 9.70 | -0.08 | -0.82% |
BlackRock U.S. Insights Long/Shrt Eq K | |||
LAFTX | 19.35 | -0.19 | -0.97% |
Lord Abbett Affiliated R5 | |||
HIEMX | 8.11 | -0.10 | -1.22% |
Virtus SGA Emerging Markets Equity I | |||
MVISX | 42.37 | -0.75 | -1.74% |
Patient Opportunity IS | |||
WPGSX | 10.10 | -0.19 | -1.85% |
WPG Partners Select Small Cap Value Ins |